Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
16
pubmed:dateCreated
2007-5-18
pubmed:abstractText
To investigate the relationship between cycloo-xygenase-2 (COX-2), and vascular endothelial growth factor (VEGF), and to determine the clinical significance of this relationship in esophageal cancer patients undergoing chemoradiotherapy (CRT).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1007-9327
pubmed:author
pubmed:issnType
Print
pubmed:day
28
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2283-8
pubmed:meshHeading
pubmed-meshheading:17511025-Adult, pubmed-meshheading:17511025-Aged, pubmed-meshheading:17511025-Carcinoma, Squamous Cell, pubmed-meshheading:17511025-Chemotherapy, Adjuvant, pubmed-meshheading:17511025-Combined Modality Therapy, pubmed-meshheading:17511025-Cyclooxygenase 2, pubmed-meshheading:17511025-Esophageal Neoplasms, pubmed-meshheading:17511025-Female, pubmed-meshheading:17511025-Gene Expression Regulation, Neoplastic, pubmed-meshheading:17511025-Humans, pubmed-meshheading:17511025-Male, pubmed-meshheading:17511025-Middle Aged, pubmed-meshheading:17511025-Neoplasm Recurrence, Local, pubmed-meshheading:17511025-Predictive Value of Tests, pubmed-meshheading:17511025-Preoperative Care, pubmed-meshheading:17511025-Prognosis, pubmed-meshheading:17511025-Radiotherapy, Adjuvant, pubmed-meshheading:17511025-Retrospective Studies, pubmed-meshheading:17511025-Risk Factors, pubmed-meshheading:17511025-Survival Analysis, pubmed-meshheading:17511025-Vascular Endothelial Growth Factor A
pubmed:year
2007
pubmed:articleTitle
Cyclooxygenase-2 expression after preoperative chemoradiotherapy correlates with more frequent esophageal cancer recurrence.
pubmed:affiliation
Second Department of Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan. yosikr2s@hyo-med.ac.jp
pubmed:publicationType
Journal Article